All In MedTech

FDA Clearance Tracker · P170029

CALCIVIS Imaging System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Mar 7, 2023 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Mar 7, 2023

Approved

Time to decision

1,988 days

Received Sep 26, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170029
Device name
CALCIVIS Imaging System
Applicant location
Edinburgh
Received
Sep 26, 2017
Decided
Mar 7, 2023
Decision
Approved
Supplements
4 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QJX

FDA's approval statement

As written in FDA's record.

Approval for The CALCIVIS Imaging System. The device is intended to be used by dental healthcare professionals on patients (6 years and older) with, or at risk of developing, demineralization associated with caries lesions, on accessible coronal tooth surfaces.The CALCIVIS Imaging System is indicated for use to provide images of active demineralization on tooth surfaces, as an aid to the assessment, diagnosis and treatment planning of demineralization associated with caries lesions.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QJX (Caries detection product with drug or biologic).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Calcivis Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.